---
title: "GIS.DE (GIS.DE) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GIS.DE/news.md"
symbol: "GIS.DE"
name: "GIS.DE"
parent: "https://longbridge.com/en/quote/GIS.DE.md"
datetime: "2026-05-20T01:34:56.807Z"
locales:
  - [en](https://longbridge.com/en/quote/GIS.DE/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GIS.DE/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GIS.DE/news.md)
---

# GIS.DE (GIS.DE) — Related News

### [ProShare Advisors LLC Buys 623,752 Shares of Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/286893590.md)
*2026-05-19T10:19:31.000Z*
> ProShare Advisors LLC increased its stake in Gilead Sciences, Inc. by 39.1% in Q4, acquiring 623,752 shares, bringing it

### [Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline](https://longbridge.com/en/news/286673327.md)
*2026-05-17T13:03:32.000Z*
> Gilead Sciences is focusing on its HIV business while expanding its oncology and inflammation pipelines through recent a

### [Gilead's new HIV drug "exceeds expectations"](https://longbridge.com/en/news/286345180.md)
*2026-05-14T02:15:28.000Z*
> Gilead Sciences' first-quarter financial report shows that total revenue increased by 4% year-on-year to $7 billion, wit

### [QinHao Pharmaceutical IPO: 762 million yuan betting agreement attracts attention](https://longbridge.com/en/news/286344995.md)
*2026-05-14T02:13:18.000Z*
> QinHao Pharmaceutical (Suzhou) Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with Huata

### [Xilio Therapeutics, Inc. 1Q 2026: Revenue $12.6M, EPS $(0.58) — 10-Q Summary](https://longbridge.com/en/news/286093557.md)
*2026-05-12T11:51:01.000Z*
> Xilio Therapeutics, Inc. reported Q1 2026 revenue of $12.6M, up from $2.9M YoY, with a net loss of $(9.5) M, an improvem

### [tech sector falters while healthcare stocks soar: dissecting today's market movements](https://longbridge.com/en/news/285963284.md)
*2026-05-11T14:46:24.000Z*
> Today's market saw the tech sector decline, with Microsoft down 1.11% and Google down 2.01%, amid concerns over high val

### [Gilead slips despite Q1 beats as it now expects 2026 loss per share](https://longbridge.com/en/news/285629987.md)
*2026-05-07T22:21:18.000Z*
> Gilead Sciences (GILD) shares fell ~2% in after-hours trading despite Q1 results exceeding expectations. The company rev